ID UBP15_BOVIN Reviewed; 952 AA. AC Q2HJE4; DT 28-NOV-2012, integrated into UniProtKB/Swiss-Prot. DT 21-MAR-2006, sequence version 1. DT 24-JAN-2024, entry version 122. DE RecName: Full=Ubiquitin carboxyl-terminal hydrolase 15; DE EC=3.4.19.12 {ECO:0000250|UniProtKB:Q9Y4E8}; DE AltName: Full=Deubiquitinating enzyme 15; DE AltName: Full=Ubiquitin thioesterase 15; DE AltName: Full=Ubiquitin-specific-processing protease 15; GN Name=USP15; OS Bos taurus (Bovine). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Bovidae; OC Bovinae; Bos. OX NCBI_TaxID=9913; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=Hereford; RX PubMed=19393038; DOI=10.1186/gb-2009-10-4-r42; RA Zimin A.V., Delcher A.L., Florea L., Kelley D.R., Schatz M.C., Puiu D., RA Hanrahan F., Pertea G., Van Tassell C.P., Sonstegard T.S., Marcais G., RA Roberts M., Subramanian P., Yorke J.A., Salzberg S.L.; RT "A whole-genome assembly of the domestic cow, Bos taurus."; RL Genome Biol. 10:R42.01-R42.10(2009). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=Hereford; TISSUE=Uterus; RG NIH - Mammalian Gene Collection (MGC) project; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. CC -!- FUNCTION: Hydrolase that removes conjugated ubiquitin from target CC proteins and regulates various pathways such as the TGF-beta receptor CC signaling, NF-kappa-B and RNF41/NRDP1-PRKN pathways. Acts as a key CC regulator of TGF-beta receptor signaling pathway, but the precise CC mechanism is still unclear: according to a report, acts by promoting CC deubiquitination of monoubiquitinated R-SMADs (SMAD1, SMAD2 and/or CC SMAD3), thereby alleviating inhibition of R-SMADs and promoting CC activation of TGF-beta target genes. According to another reports, CC regulates the TGF-beta receptor signaling pathway by mediating CC deubiquitination and stabilization of TGFBR1, leading to an enhanced CC TGF-beta signal. Able to mediate deubiquitination of monoubiquitinated CC substrates, 'Lys-27'-, 'Lys-48'- and 'Lys-63'-linked polyubiquitin CC chains. May also regulate gene expression and/or DNA repair through the CC deubiquitination of histone H2B. Acts as an inhibitor of mitophagy by CC counteracting the action of parkin (PRKN): hydrolyzes cleavage of 'Lys- CC 48'- and 'Lys-63'-linked polyubiquitin chains attached by parkin on CC target proteins such as MFN2, thereby reducing parkin's ability to CC drive mitophagy. Acts as an associated component of COP9 signalosome CC complex (CSN) and regulates different pathways via this association: CC regulates NF-kappa-B by mediating deubiquitination of NFKBIA and CC deubiquitinates substrates bound to VCP. Involved in endosome CC organization by mediating deubiquitination of SQSTM1: ubiquitinated CC SQSTM1 forms a molecular bridge that restrains cognate vesicles in the CC perinuclear region and its deubiquitination releases target vesicles CC for fast transport into the cell periphery. Acts as a negative CC regulator of antifungal immunity by mediating 'Lys-27'-linked CC deubiquitination of CARD9, thereby inactivating CARD9. CC {ECO:0000250|UniProtKB:Q9Y4E8}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide CC and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76- CC residue protein attached to proteins as an intracellular targeting CC signal).; EC=3.4.19.12; Evidence={ECO:0000250|UniProtKB:Q9Y4E8}; CC -!- SUBUNIT: A homodimer structure has been reported; however it is unclear CC whether the protein form a homodimer in vivo. Identified in a complex CC with the COP9 signalosome complex (CSN). Interacts with SMAD1, SMAD2 CC and SMAD3; the interaction is direct. Forms a complex with SMURF2 and CC SMAD7. Interacts with TGFBR1. Interacts with SART3; the interaction is CC direct. May interact with RNF20 and RNF40. May interact with PRKN. CC Interacts with INCA1. {ECO:0000250|UniProtKB:Q9Y4E8}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9Y4E8}. Nucleus CC {ECO:0000250|UniProtKB:Q9Y4E8}. Mitochondrion CC {ECO:0000250|UniProtKB:Q9Y4E8}. CC -!- PTM: Phosphorylated. Phosphorylation protects against ubiquitination CC and subsequent degradation by the proteasome. CC {ECO:0000250|UniProtKB:Q9Y4E8}. CC -!- PTM: Ubiquitinated, leading to degradation by the proteasome. CC {ECO:0000250|UniProtKB:Q9Y4E8}. CC -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; DAAA02013374; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; DAAA02013375; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; DAAA02013376; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; DAAA02013377; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; DAAA02013378; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC105521; AAI05522.1; -; mRNA. DR RefSeq; NP_001039895.1; NM_001046430.2. DR AlphaFoldDB; Q2HJE4; -. DR BMRB; Q2HJE4; -. DR SMR; Q2HJE4; -. DR STRING; 9913.ENSBTAP00000064906; -. DR MEROPS; C19.022; -. DR PaxDb; 9913-ENSBTAP00000037402; -. DR Ensembl; ENSBTAT00000078328.1; ENSBTAP00000056662.1; ENSBTAG00000010428.6. DR GeneID; 538284; -. DR KEGG; bta:538284; -. DR CTD; 9958; -. DR VEuPathDB; HostDB:ENSBTAG00000010428; -. DR VGNC; VGNC:36713; USP15. DR eggNOG; KOG1870; Eukaryota. DR GeneTree; ENSGT00940000154932; -. DR HOGENOM; CLU_001060_7_1_1; -. DR InParanoid; Q2HJE4; -. DR TreeFam; TF106276; -. DR Reactome; R-BTA-5689880; Ub-specific processing proteases. DR Proteomes; UP000009136; Chromosome 5. DR Bgee; ENSBTAG00000010428; Expressed in spermatid and 108 other cell types or tissues. DR ExpressionAtlas; Q2HJE4; baseline and differential. DR GO; GO:0005737; C:cytoplasm; ISS:UniProtKB. DR GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell. DR GO; GO:0005634; C:nucleus; ISS:UniProtKB. DR GO; GO:0004843; F:cysteine-type deubiquitinase activity; ISS:UniProtKB. DR GO; GO:0004197; F:cysteine-type endopeptidase activity; ISS:UniProtKB. DR GO; GO:0030509; P:BMP signaling pathway; ISS:UniProtKB. DR GO; GO:0035520; P:monoubiquitinated protein deubiquitination; ISS:UniProtKB. DR GO; GO:1905035; P:negative regulation of antifungal innate immune response; ISS:UniProtKB. DR GO; GO:0030512; P:negative regulation of transforming growth factor beta receptor signaling pathway; ISS:UniProtKB. DR GO; GO:1990167; P:protein K27-linked deubiquitination; ISS:UniProtKB. DR GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW. DR GO; GO:0140673; P:transcription elongation-coupled chromatin remodeling; ISS:UniProtKB. DR CDD; cd02674; Peptidase_C19R; 1. DR Gene3D; 3.90.70.10; Cysteine proteinases; 2. DR Gene3D; 3.30.2230.10; DUSP-like; 1. DR InterPro; IPR035927; DUSP-like_sf. DR InterPro; IPR038765; Papain-like_cys_pep_sf. DR InterPro; IPR006615; Pept_C19_DUSP. DR InterPro; IPR001394; Peptidase_C19_UCH. DR InterPro; IPR013792; RNA3'P_cycl/enolpyr_Trfase_a/b. DR InterPro; IPR028135; Ub_USP-typ. DR InterPro; IPR029071; Ubiquitin-like_domsf. DR InterPro; IPR029346; USP_C. DR InterPro; IPR018200; USP_CS. DR InterPro; IPR028889; USP_dom. DR PANTHER; PTHR21646; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE; 1. DR PANTHER; PTHR21646:SF28; UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 15; 1. DR Pfam; PF06337; DUSP; 1. DR Pfam; PF14836; Ubiquitin_3; 1. DR Pfam; PF00443; UCH; 1. DR Pfam; PF14533; USP7_C2; 1. DR SMART; SM00695; DUSP; 1. DR SUPFAM; SSF54001; Cysteine proteinases; 1. DR SUPFAM; SSF143791; DUSP-like; 1. DR SUPFAM; SSF55205; EPT/RTPC-like; 1. DR SUPFAM; SSF54236; Ubiquitin-like; 1. DR PROSITE; PS51283; DUSP; 1. DR PROSITE; PS00972; USP_1; 1. DR PROSITE; PS00973; USP_2; 1. DR PROSITE; PS50235; USP_3; 1. PE 2: Evidence at transcript level; KW Acetylation; Cytoplasm; Hydrolase; Mitochondrion; Nucleus; Phosphoprotein; KW Protease; Reference proteome; Thiol protease; Ubl conjugation; KW Ubl conjugation pathway. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:Q9Y4E8" FT CHAIN 2..952 FT /note="Ubiquitin carboxyl-terminal hydrolase 15" FT /id="PRO_0000420489" FT DOMAIN 7..118 FT /note="DUSP" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00613" FT DOMAIN 260..904 FT /note="USP" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01035" FT REGION 2..223 FT /note="Mediates interaction with SART3" FT /evidence="ECO:0000250|UniProtKB:Q9Y4E8" FT REGION 598..666 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 923..952 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 604..618 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 626..641 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 642..666 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT ACT_SITE 269 FT /note="Nucleophile" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10092, FT ECO:0000255|PROSITE-ProRule:PRU10093" FT ACT_SITE 862 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10092, FT ECO:0000255|PROSITE-ProRule:PRU10093" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000250|UniProtKB:Q9Y4E8" FT MOD_RES 226 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q9Y4E8" FT MOD_RES 573 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:Q8R5H1" FT MOD_RES 932 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9Y4E8" FT MOD_RES 936 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9Y4E8" SQ SEQUENCE 952 AA; 109442 MW; A4151AAE16BE8B53 CRC64; MAEGGAADLD IQRSDIATLL KTSLRKGDTW YLVDSRWFKQ WKKYVGFDSW DKYQMGDQNV YPGPIDNSGL LRDGDAQSLK EHLIDELDYI LLPTEGWNKL VSWYTLMEGQ EPIARKVVEQ GMFVKHCKVE VYLTELKLCE NGNMNNVVTR RFSKADTIDT IEKEIRKIFN IPDEKETRLW NKYMSNTFEP LNKPDSTIQD AGLYQGQVLV IEQKNEDGTW PRGPSTPNVK NSNYCLPSYT AYKNYDYSEP GRNNEQPGLC GLSNLGNTCF MNSAFQCLSN TPPLTEYFLN DKYQEELNFD NPLGMRGEIA KSYAELIKQM WSGKYSYVTP RAFKTQVGRF APQFSGYQQQ DCQELLAFLL DGLHEDLNRI RKKPYIQLKD ADGRPDKVVA EEAWENHLKR NDSIIVDIFH GLFKSTLVCP ECAKISVTFD PFCYLTLPLP MKKERTLEVY LVRMDPLTKP MQYKVVVPKI GNILDLCTAL SLLSGVPADK MIVTDIYNHR FHRIFAMDEN LSSIMERDDI YVFEININRT EDTEHVIIPV CLREKFRHSS YTHHTGSSLF GQPFLMAVPR NNTEDKLYNL LLVRMCRYVK ISTDTEDTEG SLHCCKDQNI NGNGPNGIHE EGSPSEMETD EPDDESSQDQ ELPSENENSQ SEDSVGGDND SENGLCTEET CRGQLTGHKK RLFTFQFNNL GNTDINYIKD DTRHIRFDDR QLRLDERSFL ALDWDPDLKK RYFDENAAED FEKHESVEYK PPKKPFVKLK DCIELFTTKE KLGAEDPWYC PNCKEHQQAT KKLDLWSLPP VLVVHLKRFS YSRYMRDKLD TLVDFPINDL DMSEFLINPN AGPCRYNLIA VSNHYGGMGG GHYTAFAKNK DDGKWYYFDD SSVSTASEDQ IVSKAAYVLF YQRQDTFSGT GFFPLDRETK GASAATGIPL ESDEDSNDND NDIENENCMH TN //